Dr. David Reardon on Immunotherapy and Rindopepimut in the Glioblastoma Treatment Paradigm Targeted Oncology 2:03 8 years ago 749 Скачать Далее
ASCO22: Glioblastoma research by David Reardon, MD | Dana-Farber Cancer Institute Dana-Farber Cancer Institute 1:55 2 years ago 716 Скачать Далее
Dr. Reardon Discusses the Mechanism of Action of Rindopepimut for Recurrent Glioblastoma Targeted Oncology 1:33 9 years ago 249 Скачать Далее
Immunotherapy for Brain Cancer, with David Reardon Cancer Research Institute 45:30 10 years ago 3 814 Скачать Далее
Brain Cancer and Immunotherapy with Dr. David Reardon Cancer Research Institute 33:11 2 years ago 25 752 Скачать Далее
Helping Patients with Brain Cancer: Dr. David Reardon Dana-Farber Cancer Institute 2:17 8 years ago 4 183 Скачать Далее
Dr. David Reardon on Treating Glioblastoma Patients With EGFRvIII-Mutations Targeted Oncology 1:43 8 years ago 476 Скачать Далее
Rindopepimut, Immunotherapy Combination Treatments Have Potential Brain Cancer Targeted Oncology 0:54 9 years ago 117 Скачать Далее
Dr. Reardon on Efficacy/Safety of Immunotherapy Combination in Glioblastoma OncLive 2:09 5 years ago 513 Скачать Далее
Aiming the Immune System at Brain Cancer, with David Reardon Cancer Research Institute 59:55 9 years ago 18 805 Скачать Далее
What Can I Expect from a Vaccine Trial for Glioblastoma? Ask a Scientist Cancer Research Institute 2:14 8 years ago 2 313 Скачать Далее
Dr. David Reardon on Targeting Brain Tumors and Monitoring Resistances Targeted Oncology 0:56 8 years ago 217 Скачать Далее
The Challenges in Using Immune Checkpoint Inhibitors to Treat Patients With Glioblastoma Targeted Oncology 2:01 7 years ago 328 Скачать Далее
Dr. Reardon on a Phase 1/2 Trial Examining INO-5401 and INO-9012 in Glioblastoma OncLive 2:15 3 years ago 213 Скачать Далее
Dr. Reardon on Pembrolizumab and Bevacizumab for Glioblastoma OncLive 1:34 5 years ago 980 Скачать Далее
